BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mir MA, Mehraj U. Double-crosser of the Immune System: Macrophages in Tumor Progression and Metastasis. CIR 2019;15:172-84. [DOI: 10.2174/1573395515666190611122818] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Mir MA, Mir B, Kumawat M, Alkhanani M, Jan U. Manipulation and exploitation of host immune system by pathogenic Mycobacterium tuberculosis for its advantage. Future Microbiol 2022. [PMID: 35924958 DOI: 10.2217/fmb-2022-0026] [Reference Citation Analysis]
2 Mehraj U, Aisha S, Sofi S, Mir MA. Expression pattern and prognostic significance of baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5) in breast cancer: A comprehensive analysis. Advances in Cancer Biology - Metastasis 2022;4:100037. [DOI: 10.1016/j.adcanc.2022.100037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
3 Al-Baradie RS. Nanobodies as versatile tools: A focus on targeted tumor therapy, tumor imaging and diagnostics. Hum Antibodies 2020;28:259-72. [PMID: 32831197 DOI: 10.3233/HAB-200425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Qayoom H, Mehraj U, Sofi S, Aisha S, Almilaibary A, Alkhanani M, Mir MA. Expression patterns and therapeutic implications of CDK4 across multiple carcinomas: a molecular docking and MD simulation study. Med Oncol 2022;39. [DOI: 10.1007/s12032-022-01779-9] [Reference Citation Analysis]
5 Alamoudi AO. Radiomics, aptamers and nanobodies: New insights in cancer diagnostics and imaging. Hum Antibodies 2021;29:1-15. [PMID: 33554897 DOI: 10.3233/HAB-200436] [Reference Citation Analysis]